# Effect of Roflumilast on Quality of Life, Lung Function and Mucus Properties in Patients With Bronchiectasis

> **NCT03988816** · PHASE2 · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Bronchiectasis Adult

## Interventions

- **DRUG:** Roflumilast
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT03988816
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-06
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03988816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03988816, "Effect of Roflumilast on Quality of Life, Lung Function and Mucus Properties in Patients With Bronchiectasis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03988816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*